Stifel Maintains Buy on OrthoPediatrics, Raises Price Target to $34
Portfolio Pulse from Benzinga Newsdesk
Stifel analyst Rick Wise maintains a Buy rating on OrthoPediatrics (NASDAQ:KIDS) and raises the price target from $32 to $34.
March 07, 2024 | 9:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Stifel analyst Rick Wise maintains a Buy rating on OrthoPediatrics and raises the price target from $32 to $34.
The upgrade in price target by a reputable analyst suggests a positive outlook on the stock, likely leading to increased investor confidence and potential short-term price appreciation.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100